Retatrutide is a newly developed medication that acts as a potent GLP-1 receptor activator. This revolutionary method holds significant promise for regulating type 2 diabetes. By imitating the actions of natural GLP-1, Retatrutide improves insulin secretion and limits glucagon release, leading to improved glycemic control. Clinical trials have demo